Cite
HARVARD Citation
Barbanti, P. et al. (2021). Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study. Headache. 61 (2), pp. 363-372. [Online].